单剂口服阿片与非阿片镇痛药对急诊急性肢体疼痛的随机临床试验
该随机临床试验在纽约布朗克斯2个城市急诊科纳入416例21至64岁中重度急性肢体疼痛患者,比较4种口服镇痛方案2小时疼痛缓解差异。结果显示各组NRS评分下降差异无统计学意义(P=0.053),最大组间差异0.9低于预设最小临床重要差值1.3。作者认为单剂布洛芬联合对乙酰氨基酚与3种阿片联合对乙酰氨基酚方案在2小时疼痛缓解上无统计学显著或临床重要差异。
要点
- 4组2小时NRS疼痛评分下降分别为4.3、4.4、3.5、3.9,总体比较P=0.053。
- 最大组间差异为羟考酮组与氢可酮组间0.9(99.2%CI -0.1至1.8),低于1.3阈值。
- 作者结论:单剂布洛芬联合对乙酰氨基酚与阿片联合方案在2小时疼痛缓解上无显著差异。
核心结论
- 对于急诊急性肢体疼痛患者,单剂布洛芬联合对乙酰氨基酚与3种阿片联合对乙酰氨基酚方案在2小时疼痛缓解上无统计学显著或临床重要差异。
- 作者认为可能需要进一步研究评估不良事件和其他给药方案。
研究设计与样本
- 随机临床试验,在纽约布朗克斯2个城市急诊科开展,2015年7月至2016年8月纳入416例21至64岁中重度急性肢体疼痛患者。
- 每种联合镇痛方案组104例;411例纳入分析(平均[SD]年龄37[12]岁;199例[48%]女性;247例[60%]拉丁裔)。
主要发现
- 基线平均NRS疼痛评分为8.7(SD 1.3)。
- 2小时NRS评分下降:布洛芬联合对乙酰氨基酚组4.3(95%CI 3.6至4.9);羟考酮联合对乙酰氨基酚组4.4(95%CI 3.7至5.0);氢可酮联合对乙酰氨基酚组3.5(95%CI 2.9至4.2);可待因联合对乙酰氨基酚组3.9(95%CI 3.2至4.5);总体比较P=0.053。
- 基线至2小时NRS评分下降最大组间差异为羟考酮联合对乙酰氨基酚组与氢可酮联合对乙酰氨基酚组之间0.9(99.2%CI -0.1至1.8),低于预设最小临床重要差值1.3。
- 未评估不良事件。
关键数值与推荐
- 主要结局为服药后2小时疼痛下降的组间差异,疼痛采用11点数字评定量表(NRS,0为无痛,10为最痛)评估,预设最小临床重要差值为1.3。
- 干预方案:布洛芬400 mg联合对乙酰氨基酚1000 mg;羟考酮5 mg联合对乙酰氨基酚325 mg;氢可酮5 mg联合对乙酰氨基酚300 mg;可待因30 mg联合对乙酰氨基酚300 mg。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未评估不良事件。
- 作者认为可能需要进一步研究评估不良事件和其他给药方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The choice of analgesic to treat acute pain in the emergency department (ED) lacks a clear evidence base. The combination of ibuprofen and acetaminophen (paracetamol) may represent a viable nonopioid alternative. OBJECTIVES: To compare the efficacy of 4 oral analgesics. DESIGN, SETTINGS, AND PARTICIPANTS: Randomized clinical trial conducted at 2 urban EDs in the Bronx, New York, that included 416 patients aged 21 to 64 years with moderate to severe acute extremity pain enrolled from July 2015 to August 2016. INTERVENTIONS: Participants (104 per each combination analgesic group) received 400 mg of ibuprofen and 1000 mg of acetaminophen; 5 mg of oxycodone and 325 mg of acetaminophen; 5 mg of hydrocodone and 300 mg of acetaminophen; or 30 mg of codeine and 300 mg of acetaminophen. MAIN OUTCOMES AND MEASURES: The primary outcome was the between-group difference in decline in pain 2 hours after ingestion. Pain intensity was assessed using an 11-point numerical rating scale (NRS), in which 0 indicates no pain and 10 indicates the worst possible pain. The predefined minimum clinically important difference was 1.3 on the NRS. Analysis of variance was used to test the overall between-group difference at P = .05 and 99.2% CIs adjusted for multiple pairwise comparisons. RESULTS: Of 416 patients randomized, 411 were analyzed (mean [SD] age, 37 [12] years; 199 [48%] women; 247 [60%] Latino). The baseline mean NRS pain score was 8.7 (SD, 1.3). At 2 hours, the mean NRS pain score decreased by 4.3 (95% CI, 3.6 to 4.9) in the ibuprofen and acetaminophen group; by 4.4 (95% CI, 3.7 to 5.0) in the oxycodone and acetaminophen group; by 3.5 (95% CI, 2.9 to 4.2) in the hydrocodone and acetaminophen group; and by 3.9 (95% CI, 3.2 to 4.5) in the codeine and acetaminophen group (P = .053). The largest difference in decline in the NRS pain score from baseline to 2 hours was between the oxycodone and acetaminophen group and the hydrocodone and acetaminophen group (0.9; 99.2% CI, -0.1 to 1.8), which was less than the minimum clinically important difference in NRS pain score of 1.3. Adverse events were not assessed. CONCLUSIONS AND RELEVANCE: For patients presenting to the ED with acute extremity pain, there were no statistically significant or clinically important differences in pain reduction at 2 hours among single-dose treatment with ibuprofen and acetaminophen or with 3 different opioid and acetaminophen combination analgesics. Further research to assess adverse events and other dosing may be warranted. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02455518.
引用
- Chang AK, Bijur PE, Esses D, et al. Effect of a Single Dose of Oral Opioid and Nonopioid Analgesics on Acute Extremity Pain in the Emergency Department: A Randomized Clinical Trial. JAMA. 2017. PMID: 29114833. doi:10.1001/jama.2017.16190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。